Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Ensysce Biosciences Inc (NQ: ENSC ) 0.5679 -0.0237 (-4.01%) Streaming Delayed Price Updated: 12:54 PM EDT, May 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 51,855 Open 0.5916 Bid (Size) 0.5520 (29) Ask (Size) 0.6089 (31) Prev. Close 0.5916 Today's Range 0.5600 - 0.6096 52wk Range 0.5300 - 3.980 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Ensysce Biosciences’ CEO Dr. Lynn Kirkpatrick Featured in Xtalks Clinical Edge Magazine April 25, 2024 Via ACCESSWIRE Ensysce Biosciences' Presentation from the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference Published April 19, 2024 Via ACCESSWIRE Performance YTD -48.84% -48.84% 1 Month -27.19% -27.19% 3 Month -60.56% -60.56% 6 Month -38.35% -38.35% 1 Year -84.57% -84.57% More News Read More Ensysce Biosciences to Participate in the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference April 09, 2024 Via ACCESSWIRE FSR Stock: The $150 Million Reason Fisker Shares Are Moving Today March 18, 2024 Via InvestorPlace ENSC Stock Earnings: Ensysce Biosciences Misses EPS, Beats Revenue for Q4 2023 March 18, 2024 Via InvestorPlace Ensysce Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results March 15, 2024 Via ACCESSWIRE Ensysce Biosciences Announces Successful Meeting with FDA for PF614-MPAR, a Next Generation Opioid with Overdose Protection February 21, 2024 Via ACCESSWIRE Ensysce Biosciences Announces Publication of Clinical Bioequivalence Manuscript February 15, 2024 Via ACCESSWIRE Ensysce Biosciences Selected to Present at American Association of Pain Medicine Annual Conference February 06, 2024 Via ACCESSWIRE Ensysce Biosciences Receives Positive Nasdaq Listing Determination February 27, 2024 Via ACCESSWIRE 12 Health Care Stocks Moving In Tuesday's Pre-Market Session February 13, 2024 Via Benzinga Ensysce Biosciences, Inc. Announces Exercise of Warrants for $4.7 Million Gross Proceeds February 13, 2024 Via ACCESSWIRE 12 Health Care Stocks Moving In Wednesday's After-Market Session January 31, 2024 Via Benzinga Ensysce Biosciences Announces Positive End of Phase 2 Meeting with FDA for PF614 to Treat Severe Pain January 31, 2024 Via ACCESSWIRE Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session January 31, 2024 Via Benzinga Ensysce Biosciences to Present Groundbreaking Oral Overdose Protection for Opioids at the 5th Annual NIH HEAL Meeting January 25, 2024 Via ACCESSWIRE Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session January 24, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session January 24, 2024 Via Benzinga Why Netflix Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket January 24, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session January 23, 2024 Via Benzinga Crude Oil Down 1%; Lockheed Martin Earnings Top Views January 23, 2024 Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Opioid Developer Ensysce Biosciences Stock Is Shooting Higher Today - Here's Why January 23, 2024 Via Benzinga Exposures Product Safety 12 Health Care Stocks Moving In Tuesday's Intraday Session January 23, 2024 Via Benzinga Dow Tumbles 150 Points; Procter & Gamble Shares Rise On Upbeat Earnings January 23, 2024 Via Benzinga Topics Stocks Exposures US Equities Why 3M Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session January 23, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
